Cencora (NYSE:COR) CEO Sells $1,868,397.44 in Stock

Cencora, Inc. (NYSE:COR) CEO Robert Mauch sold 5,096 shares of the firm’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $366.64, for a total value of $1,868,397.44. Following the transaction, the chief executive officer owned 65,746 shares in the company, valued at $24,105,113.44. The trade was a 7.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Cencora Stock Down 0.2%

Shares of NYSE:COR traded down $0.85 during trading hours on Wednesday, hitting $360.79. The company’s stock had a trading volume of 1,216,894 shares, compared to its average volume of 1,541,989. The firm’s fifty day moving average price is $323.97 and its 200 day moving average price is $303.25. The company has a debt-to-equity ratio of 3.64, a current ratio of 0.90 and a quick ratio of 0.53. The company has a market capitalization of $69.95 billion, a price-to-earnings ratio of 37.12, a P/E/G ratio of 1.56 and a beta of 0.63. Cencora, Inc. has a 52 week low of $223.92 and a 52 week high of $369.00.

Cencora (NYSE:COR) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $3.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.79 by $0.05. Cencora had a return on equity of 267.36% and a net margin of 0.60%.The business had revenue of $83.73 billion for the quarter, compared to the consensus estimate of $83.36 billion. During the same period last year, the business posted $3.34 EPS. The business’s revenue was up 5.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.450-17.75 EPS. As a group, research analysts expect that Cencora, Inc. will post 15.37 EPS for the current year.

Cencora Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 1st. Stockholders of record on Friday, November 14th will be given a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Friday, November 14th. This is an increase from Cencora’s previous quarterly dividend of $0.55. Cencora’s payout ratio is presently 30.19%.

Analysts Set New Price Targets

Several equities research analysts have weighed in on COR shares. JPMorgan Chase & Co. raised their target price on shares of Cencora from $344.00 to $417.00 and gave the company an “overweight” rating in a research note on Tuesday, November 11th. TD Cowen increased their price target on Cencora from $350.00 to $400.00 and gave the company a “buy” rating in a research note on Monday, November 10th. Wells Fargo & Company increased their price objective on shares of Cencora from $354.00 to $405.00 and gave the company an “overweight” rating in a research report on Tuesday, November 11th. UBS Group raised their price target on shares of Cencora from $380.00 to $415.00 and gave the stock a “buy” rating in a report on Friday, November 7th. Finally, Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Cencora in a research report on Thursday, October 30th. Nine analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Cencora currently has a consensus rating of “Moderate Buy” and a consensus price target of $371.09.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vestcor Inc increased its holdings in Cencora by 0.5% during the 3rd quarter. Vestcor Inc now owns 5,196 shares of the company’s stock worth $1,624,000 after purchasing an additional 28 shares during the last quarter. Cornerstone Wealth Group LLC grew its position in shares of Cencora by 1.3% during the third quarter. Cornerstone Wealth Group LLC now owns 2,383 shares of the company’s stock worth $745,000 after buying an additional 30 shares in the last quarter. Security Financial Services INC. increased its stake in shares of Cencora by 2.6% in the third quarter. Security Financial Services INC. now owns 1,325 shares of the company’s stock worth $414,000 after buying an additional 33 shares during the last quarter. Atlantic Edge Private Wealth Management LLC raised its holdings in Cencora by 70.0% in the second quarter. Atlantic Edge Private Wealth Management LLC now owns 85 shares of the company’s stock valued at $25,000 after acquiring an additional 35 shares in the last quarter. Finally, Hemington Wealth Management boosted its stake in Cencora by 12.0% during the 3rd quarter. Hemington Wealth Management now owns 327 shares of the company’s stock valued at $102,000 after acquiring an additional 35 shares during the last quarter. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Cencora Company Profile

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.